Number of Shares
270.00
Current Holdings Value*
$48,680.00
% of Portfolio
1.51%
Total Estimate Gain
$-8,421.60
% of Total Estimate Gain
-15.32%

S&P SmallCap 600 Pure Growth Fund's Krystal Biotech Inc Holding Summary

As of 2025-03-31, RYDEX SERIES FUNDS held 270.00 shares of Krystal Biotech Inc(KRYS), totaling $48,680.00. This investment constitutes 1.51% of their stock portfolio, and RYDEX SERIES FUNDS now holds 0% of the outstanding Krystal Biotech Inc(KRYS) stock.

The initial trade took place in 2024Q4. And since then S&P SmallCap 600 Pure Growth Fund has made 1 purchases of KRYS, at an average price of $177.33, for a total of 310.00 shares. In addition, there have been 1 sales at an average price of $168.21 for 40.00 shares. Based on historical transaction data and KRYS's current price of $147.49, S&P SmallCap 600 Pure Growth Fund's estimated gain on his KRYS holdings is $-8,421.60, reflecting a -15.32% gain to date.

S&P SmallCap 600 Pure Growth Fund KRYS ($147.49) Holding Chart

S&P SmallCap 600 Pure Growth Fund KRYS ($147.49) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1